1 |
Revel M, Sautès-fridman C, Fridman W, Roumenina LT. C1q+ macrophages: passengers or drivers of cancer progression. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.02.006] [Reference Citation Analysis]
|
2 |
Kmiecik AM, Dzięgiel P, Podhorska-Okołów M. Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule? Int J Mol Sci 2021;22:8313. [PMID: 34361082 DOI: 10.3390/ijms22158313] [Reference Citation Analysis]
|
3 |
Zhang X, Li Y, Chen X, Jin B, Shu C, Ni W, Jiang Y, Zhang J, Ma L, Shu J. Single-cell transcriptome analysis uncovers the molecular and cellular characteristics of thin endometrium. FASEB J 2022;36:e22193. [PMID: 35201635 DOI: 10.1096/fj.202101579R] [Reference Citation Analysis]
|
4 |
Setlai BP, Hull R, Bida M, Durandt C, Mulaudzi TV, Chatziioannou A, Dlamini Z. Immunosuppressive Signaling Pathways as Targeted Cancer Therapies. Biomedicines 2022;10:682. [DOI: 10.3390/biomedicines10030682] [Reference Citation Analysis]
|
5 |
Huang C, Iovanna J, Santofimia-Castaño P. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. Int J Mol Sci 2021;22:4970. [PMID: 34067040 DOI: 10.3390/ijms22094970] [Reference Citation Analysis]
|
6 |
Fleming Martinez AK, Döppler HR, Bastea LI, Edenfield BH, Liou G, Storz P. Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. iScience 2022;25:104327. [DOI: 10.1016/j.isci.2022.104327] [Reference Citation Analysis]
|
7 |
Kadiyala P, Elhossiny AM, Carpenter ES. Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer. Front Oncol 2022;12:881871. [DOI: 10.3389/fonc.2022.881871] [Reference Citation Analysis]
|
8 |
Yao J, Duan L, Huang X, Liu J, Fan X, Xiao Z, Yan R, Liu H, An G, Hu B, Ge Y. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:769727. [PMID: 34926275 DOI: 10.3389/fonc.2021.769727] [Reference Citation Analysis]
|